Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRQR
#3700
ProQR Therapeutics N.V. - Ordinary Shares
1.7
4
USD
+0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.35%
Monthly Change
+19.18%
6 month change
+5.45%
Year Change
-29.84%
Previous Close
1.7
0
Open
1.7
4
Low
1.7
1
High
1.7
6
Volume
183
Markets
US Stock Market
Healthcare
Biotechnology
PRQR
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
54.13 M
71.29 M
80.82 M
81.35 M
105.21 M
105.36 M
105.36 M
Valuation ratios
Enterprise value
227.35 M
571.04 M
275.59 M
168.81 M
278.81 M
212.83 M
180.17 M
Price to earnings ratio
—
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
—
—
—
—
—
—
Return on equity %
—
—
—
—
—
—
—
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
—
—
—
—
—
—
—
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
—
News
ProQR Therapeutics: Human NTCP Data Strengthens The Axiomer Thesis (NASDAQ:PRQR)
ProQR Therapeutics N.V. (PRQR) Presents at TIDES USA 2026 - Slideshow (NASDAQ:PRQR) 2026-05-15
Kamada (KMDA) Misses Q1 Earnings and Revenue Estimates
Earnings Preview: ProQR (PRQR) Q1 Earnings Expected to Decline
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates
ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript
ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2026-04-08
ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript
Citizens reiterates ProQR Therapeutics stock rating on RNA editing platform potential
ProQR Therapeutics NV earnings beat by €0.02, revenue topped estimates
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates